These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 38807101

  • 21. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H, Cao W, Xue J.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1074-1081. PubMed ID: 30553445
    [Abstract] [Full Text] [Related]

  • 22. Long non-coding RNA RBM5-AS1 promotes the aggressive behaviors of oral squamous cell carcinoma by regulation of miR-1285-3p/YAP1 axis.
    Li C, Ye J, Zhang Z, Gong Z, Lin Z, Ding M.
    Biomed Pharmacother; 2020 Mar 22; 123():109723. PubMed ID: 31869662
    [Abstract] [Full Text] [Related]

  • 23. LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p/SEMA3A axis.
    Qin SY, Li B, Liu JM, Lv QL, Zeng XL.
    Kaohsiung J Med Sci; 2024 Oct 22; 40(10):877-889. PubMed ID: 39177014
    [Abstract] [Full Text] [Related]

  • 24. FOXD1-AS1 upregulates FOXD1 to promote oral squamous cell carcinoma progression.
    Ma Y, Han J, Luo X.
    Oral Dis; 2023 Mar 22; 29(2):604-614. PubMed ID: 34403535
    [Abstract] [Full Text] [Related]

  • 25. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S, Wang X, Guo X, Lu Z.
    J Oral Pathol Med; 2022 Mar 22; 51(3):272-280. PubMed ID: 34637162
    [Abstract] [Full Text] [Related]

  • 26. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B.
    Cancer Med; 2017 Dec 22; 6(12):2897-2908. PubMed ID: 29125238
    [Abstract] [Full Text] [Related]

  • 27. Long non-coding RNA TTN-AS1/microRNA-199a-3p/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma.
    Jin Z, Jiang S.
    Bioengineered; 2021 Dec 22; 12(1):7724-7736. PubMed ID: 34606420
    [Abstract] [Full Text] [Related]

  • 28. Long noncoding RNA TUG1 regulates the development of oral squamous cell carcinoma through sponging miR-524-5p to mediate DLX1 expression as a competitive endogenous RNA.
    Liu S, Liu LH, Hu WW, Wang M.
    J Cell Physiol; 2019 Nov 22; 234(11):20206-20216. PubMed ID: 30980391
    [Abstract] [Full Text] [Related]

  • 29. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F, Chang H, Gao G, Zhang B, Li X, Jin B.
    J Cell Biochem; 2019 Jun 22; 120(6):9324-9336. PubMed ID: 30520141
    [Abstract] [Full Text] [Related]

  • 30. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
    Liu Z, Li H, Fan S, Lin H, Lian W.
    Cancer Biol Ther; 2019 Jun 22; 20(4):444-453. PubMed ID: 30404566
    [Abstract] [Full Text] [Related]

  • 31. Downregulation of lncRNA FOXD2-AS1 Confers Radiosensitivity to Gastric Cancer Cells via miR-1913/SETD1A Axis.
    Guo F, Guo R, Zhang L.
    Cytogenet Genome Res; 2022 Jun 22; 162(1-2):10-27. PubMed ID: 35354145
    [Abstract] [Full Text] [Related]

  • 32. Long non-coding RNA LINC01207 promotes cell proliferation and migration but suppresses apoptosis and autophagy in oral squamous cell carcinoma by the microRNA-1301-3p/lactate dehydrogenase isoform A axis.
    Lu X, Chen L, Li Y, Huang R, Meng X, Sun F.
    Bioengineered; 2021 Dec 22; 12(1):7780-7793. PubMed ID: 34463208
    [Abstract] [Full Text] [Related]

  • 33. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y, Zhang S, Min Z, Yu Z, Zhang H, Jiao J.
    BMC Cancer; 2021 Oct 07; 21(1):1085. PubMed ID: 34620126
    [Abstract] [Full Text] [Related]

  • 34. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
    Ni W, Xia Y, Bi Y, Wen F, Hu D, Luo L.
    Aging (Albany NY); 2019 Mar 11; 11(5):1427-1439. PubMed ID: 30860979
    [Abstract] [Full Text] [Related]

  • 35. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis.
    Lu T, Liu H, You G.
    Int J Mol Med; 2018 Dec 11; 42(6):3291-3299. PubMed ID: 30280186
    [Abstract] [Full Text] [Related]

  • 36. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y, He H, Sui W, Zhang J, Zhang S, Yang D.
    Int J Oncol; 2018 Mar 11; 52(3):901-912. PubMed ID: 29344674
    [Abstract] [Full Text] [Related]

  • 37. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
    Du Y, Shuai Y, Wang H, Li H, Li Y.
    Turk J Med Sci; 2023 Jun 11; 53(3):630-639. PubMed ID: 37476905
    [Abstract] [Full Text] [Related]

  • 38. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p.
    Luo D, Salai A, Lv H, Wang Y, Gao Y.
    Clin Transl Oncol; 2022 Oct 11; 24(10):1954-1963. PubMed ID: 35778646
    [Abstract] [Full Text] [Related]

  • 39. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Duan Q, Xu M, Wu M, Zhang X, Gan M, Jiang H.
    Cancer Med; 2020 May 11; 9(9):3115-3129. PubMed ID: 32130788
    [Abstract] [Full Text] [Related]

  • 40. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
    Chen ZF, Wang Y, Sun LL, Ding SY, Jinag H.
    Eur Rev Med Pharmacol Sci; 2020 May 11; 24(10):5436-5445. PubMed ID: 32495922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.